Loading clinical trials...
Loading clinical trials...
A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial of ADI-PEG 20 or Placebo in Subjects With Nonalcoholic Steatohepatitis (NASH)
Conditions
Interventions
ADI-PEG20
Placebo
Locations
10
Taiwan
Ditmanson Medical Foundation Chiayi Christian Hospital；Chiayi Christian Hospital (CYCH)
Chiayi City, Taiwan, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital(KMUH)
Kaohsiung, Taiwan, Taiwan
E-Da Hospital (EDH)
Kaohsiung, Taiwan, Taiwan
Chang Gung Medical Foundation-Kaohsiung (CGMF-KS)
Kaohsiung, Taiwan, Taiwan
Chang Gung Medical Foundation-Keelung (CGMF-KL)
Keelung, Taiwan, Taiwan
National Cheng Kung University Hospital (NCKUH)
Tainan, Taiwan, Taiwan
Start Date
September 13, 2023
Primary Completion Date
December 31, 2027
Completion Date
January 31, 2028
Last Updated
September 23, 2025
NCT06318169
NCT06216041
NCT04104321
NCT02443116
NCT04616014
NCT06037577
Lead Sponsor
Polaris Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions